{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T14:24:49Z","timestamp":1786458289333,"version":"build-2736575974"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004663","name":"the Ministry of Science and Technology, Taiwan","doi-asserted-by":"crossref","award":["MOST 108-2314-B-182A-006-MY3"],"award-info":[{"award-number":["MOST 108-2314-B-182A-006-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004663","name":"the Ministry of Science and Technology, Taiwan","doi-asserted-by":"crossref","award":["108-2320-B-182A-023-MY3"],"award-info":[{"award-number":["108-2320-B-182A-023-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004663","name":"the Ministry of Science and Technology, Taiwan","doi-asserted-by":"crossref","award":["109-2320-B-182A-008-MY3"],"award-info":[{"award-number":["109-2320-B-182A-008-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004663","name":"the Ministry of Science and Technology, Taiwan","doi-asserted-by":"crossref","award":["110-2320-B-182A-014 -MY3"],"award-info":[{"award-number":["110-2320-B-182A-014 -MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004663","name":"the Ministry of Science and Technology, Taiwan","doi-asserted-by":"crossref","award":["108-2314-B-182A-104-MY3"],"award-info":[{"award-number":["108-2314-B-182A-104-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004663","name":"the Ministry of Science and Technology, Taiwan","doi-asserted-by":"crossref","award":["110-2326-B-182A-003-"],"award-info":[{"award-number":["110-2326-B-182A-003-"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG2J0221-2"],"award-info":[{"award-number":["CMRPG2J0221-2"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG3L0491"],"award-info":[{"award-number":["CMRPG3L0491"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG3I0381-2"],"award-info":[{"award-number":["CMRPG3I0381-2"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CIRPG3I0024-5"],"award-info":[{"award-number":["CIRPG3I0024-5"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CIRPG3I0044-5"],"award-info":[{"award-number":["CIRPG3I0044-5"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CIRPG2I0014-5"],"award-info":[{"award-number":["CIRPG2I0014-5"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s40257-022-00721-z","type":"journal-article","created":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T09:04:12Z","timestamp":1662023052000},"page":"775-799","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["New Onset and Exacerbations of Psoriasis Following COVID-19 Vaccines: A Systematic Review"],"prefix":"10.1007","volume":"23","author":[{"given":"Po-Chien","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Hsin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuang-Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Chang","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hung","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7378-4235","authenticated-orcid":false,"given":"Chun-Bing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,1]]},"reference":[{"issue":"9","key":"721_CR1","doi-asserted-by":"publisher","first-page":"944","DOI":"10.3390\/vaccines9090944","volume":"9","author":"D Niebel","year":"2021","unstructured":"Niebel D, Novak N, Wilhelmi J, Ziob J, Wilsmann-Theis D, Bieber T, et al. Cutaneous adverse reactions to COVID-19 vaccines: insights from an immuno-dermatological perspective. Vaccines (Basel). 2021;9(9):944.","journal-title":"Vaccines (Basel)."},{"key":"721_CR2","unstructured":"Ritchie H, Mathieu E, Rod\u00e9s-Guirao L, Appel C, Giattino C, Ortiz-Ospina E, et al. Coronavirus Pandemic (COVID-19). OurWorldInData.org; 2020. https:\/\/ourworldindata.org\/coronavirus."},{"issue":"22","key":"721_CR3","doi-asserted-by":"publisher","first-page":"5344","DOI":"10.3390\/jcm10225344","volume":"10","author":"F Bellinato","year":"2021","unstructured":"Bellinato F, Maurelli M, Gisondi P, Girolomoni G. Cutaneous adverse reactions associated with SARS-CoV-2 vaccines. J Clin Med. 2021;10(22):5344.","journal-title":"J Clin Med"},{"issue":"4","key":"721_CR4","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.det.2021.05.016","volume":"39","author":"Q Sun","year":"2021","unstructured":"Sun Q, Fathy R, McMahon DE, Freeman EE. COVID-19 vaccines and the skin: the landscape of cutaneous vaccine reactions worldwide. Dermatol Clin. 2021;39(4):653\u201373.","journal-title":"Dermatol Clin"},{"issue":"5","key":"721_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15085","volume":"34","author":"P Nagrani","year":"2021","unstructured":"Nagrani P, Jindal R, Goyal D. Onset\/flare of psoriasis following the ChAdOx1 nCoV-19 Corona virus vaccine (Oxford-AstraZeneca\/Covishield): report of two cases. Dermatol Ther. 2021;34(5): e15085.","journal-title":"Dermatol Ther"},{"issue":"6","key":"721_CR6","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15129","volume":"34","author":"MC Pedrazini","year":"2021","unstructured":"Pedrazini MC, da Silva MH. Pityriasis rosea-like cutaneous eruption as a possible dermatological manifestation after Oxford-AstraZeneca vaccine: case report and brief literature review. Dermatol Ther. 2021;34(6): e15129.","journal-title":"Dermatol Ther"},{"key":"721_CR7","doi-asserted-by":"crossref","unstructured":"Pauluzzi M, Stinco G, Errichetti E. Bullous pemphigoid in a young male after COVID-19 mRNA vaccine: a report and brief literature review. J Eur Acad Dermatol Venereol. 2021;36(4):e257\u20139.","DOI":"10.1111\/jdv.17891"},{"issue":"6","key":"721_CR8","first-page":"94","volume":"18","author":"CZ Yu Phuan","year":"2021","unstructured":"Yu Phuan CZ, Ci-En Choi E, Oon HH. Temporary exacerbation of pre-existing psoriasis and eczema in the context of COVID-19 mRNA booster vaccination: a case report and review of the literature. JAAD Int. 2021;18(6):94\u20136.","journal-title":"JAAD Int."},{"key":"721_CR9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jdcr.2021.11.016","volume":"19","author":"N Wei","year":"2022","unstructured":"Wei N, Kresch M, Elbogen E, Lebwohl M. New onset and exacerbation of psoriasis after COVID-19 vaccination. JAAD Case Rep. 2022;19:74\u20137.","journal-title":"JAAD Case Rep."},{"issue":"12","key":"721_CR10","doi-asserted-by":"publisher","first-page":"e857","DOI":"10.1111\/jdv.17582","volume":"35","author":"E Sotiriou","year":"2021","unstructured":"Sotiriou E, Tsentemeidou A, Bakirtzi K, Lallas A, Ioannides D, Vakirlis E. Psoriasis exacerbation after COVID-19 vaccination: a report of 14 cases from a single centre. J Eur Acad Dermatol Venereol. 2021;35(12):e857\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"721_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jdcr.2021.08.035","volume":"17","author":"D Perna","year":"2021","unstructured":"Perna D, Jones J, Schadt CR. Acute generalized pustular psoriasis exacerbated by the COVID-19 vaccine. JAAD Case Rep. 2021;17:1\u20133.","journal-title":"JAAD Case Rep."},{"issue":"1","key":"721_CR12","doi-asserted-by":"publisher","first-page":"E11","DOI":"10.1111\/jdv.17665","volume":"36","author":"M Megna","year":"2022","unstructured":"Megna M, Potestio L, Gallo L, Caiazzo G, Ruggiero A, Fabbrocini G. Reply to \u201cPsoriasis exacerbation after COVID-19 vaccination: report of 14 cases from a single centre\u201d by Sotiriou E et al. J Eur Acad Dermatol Venereol. 2022;36(1):E11\u20133.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"1","key":"721_CR13","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jaad.2021.03.092","volume":"85","author":"DE McMahon","year":"2021","unstructured":"McMahon DE, Amerson E, Rosenbach M, Lipoff JB, Moustafa D, Tyagi A, et al. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases. J Am Acad Dermatol. 2021;85(1):46\u201355.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"721_CR14","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jaad.2021.09.002","volume":"86","author":"DE McMahon","year":"2022","unstructured":"McMahon DE, Kovarik CL, Damsky W, Rosenbach M, Lipoff JB, Tyagi A, et al. Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: a registry-based study. J Am Acad Dermatol. 2022;86(1):113\u201321.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"721_CR15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4103\/ds.ds_33_19","volume":"38","author":"C-C Chi","year":"2020","unstructured":"Chi C-C, Fang T-P, Lin Y-C. Association of psoriasis with asthma: a systematic review and meta-analysis of observational studies. Dermatol Sin. 2020;38(1):22\u20137.","journal-title":"Dermatol Sin"},{"issue":"3","key":"721_CR16","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.dsi.2017.11.001","volume":"36","author":"YX Dai","year":"2018","unstructured":"Dai YX, Chen TJ, Chang YT. Skin care services and disease prevalence in Taiwan: a nationwide study. Dermatol Sin. 2018;36(3):124\u201330.","journal-title":"Dermatol Sin"},{"issue":"9997","key":"721_CR17","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","volume":"386","author":"W-H Boehncke","year":"2015","unstructured":"Boehncke W-H, Sch\u00f6n MP. Psoriasis. Lancet. 2015;386(9997):983\u201394.","journal-title":"Lancet"},{"issue":"2","key":"721_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4103\/ds.ds_51_20","volume":"39","author":"T-F Tsai","year":"2021","unstructured":"Tsai T-F, Lo Y, Huang Y-H. Long-term effectiveness and safety of ixekizumab in the treatment of 14 patients with a history of chronic erythrodermic psoriasis who failed prior secukinumab: a bicentric retrospective study. Dermatol Sin. 2021;39(2):87.","journal-title":"Dermatol Sin"},{"issue":"6","key":"721_CR19","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3390\/ijms20061475","volume":"20","author":"A Rendon","year":"2019","unstructured":"Rendon A, Schakel K. Psoriasis pathogenesis and treatment. Int J Mol Sci. 2019;20(6):1475.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"721_CR20","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/j.jaad.2021.07.054","volume":"85","author":"S Wack","year":"2021","unstructured":"Wack S, Patton T, Ferris LK. COVID-19 vaccine safety and efficacy in patients with immune-mediated inflammatory disease: review of available evidence. J Am Acad Dermatol. 2021;85(5):1274\u201384.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"721_CR21","doi-asserted-by":"publisher","first-page":"e361","DOI":"10.1111\/jdv.17200","volume":"35","author":"P Gisondi","year":"2021","unstructured":"Gisondi P, Geat D, Naldi L, Piaserico S. Insights into Sars-CoV-2 vaccination in patients with chronic plaque psoriasis on systemic treatments. J Eur Acad Dermatol Venereol. 2021;35(6):e361\u20132.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"15","key":"721_CR22","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.3390\/jcm10153355","volume":"10","author":"N Skroza","year":"2021","unstructured":"Skroza N, Bernardini N, Tolino E, Proietti I, Mambrin A, Marchesiello A, et al. Safety and impact of anti-COVID-19 vaccines in psoriatic patients treated with biologics: a real life experience. J Clin Med. 2021;10(15):3355.","journal-title":"J Clin Med"},{"issue":"10","key":"721_CR23","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1136\/annrheumdis-2021-220647","volume":"80","author":"V Furer","year":"2021","unstructured":"Furer V, Eviatar T, Zisman D, Peleg H, Paran D, Levartovsky D, et al. Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study. Ann Rheum Dis. 2021;80(10):1330\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"721_CR24","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1002\/art.41928","volume":"73","author":"JR Curtis","year":"2021","unstructured":"Curtis JR, Johnson SR, Anthony DD, Arasaratnam RJ, Baden LR, Bass AR, et al. American College of Rheumatology Guidance for COVID-19 vaccination in patients with rheumatic and musculoskeletal diseases: version 3. Arthritis Rheumatol. 2021;73(10):e60\u201375.","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"721_CR25","doi-asserted-by":"publisher","first-page":"169","DOI":"10.4103\/ds.ds_50_21","volume":"39","author":"C-H Lee","year":"2021","unstructured":"Lee C-H, Huang Y-H, Chu C-Y. Taiwan dermatological association recommendations for coronavirus disease of 2019 vaccination in patients treated with immunotherapeutics. Dermatol Sin. 2021;39(4):169\u201374.","journal-title":"Dermatol Sin"},{"issue":"4","key":"721_CR26","doi-asserted-by":"publisher","first-page":"208","DOI":"10.4103\/ds.ds_45_21","volume":"39","author":"J-P Chao","year":"2021","unstructured":"Chao J-P, Tsai T-F. Psoriasis flare following ChAdOx1-S\/nCoV-19 vaccination in patients with psoriasis under biologic treatment. Dermatol Sin. 2021;39(4):208\u20139.","journal-title":"Dermatol Sin"},{"key":"721_CR27","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jdcr.2021.09.009","volume":"17","author":"JW Ricardo","year":"2021","unstructured":"Ricardo JW, Lipner SR. Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine. JAAD Case Rep. 2021;17:18\u201320.","journal-title":"JAAD Case Rep."},{"issue":"2","key":"721_CR28","doi-asserted-by":"publisher","first-page":"e80","DOI":"10.1111\/jdv.17690","volume":"36","author":"D Pesqu\u00e9","year":"2022","unstructured":"Pesqu\u00e9 D, Lopez-Trujillo E, Marcantonio O, Gim\u00e9nez-Arnau AM, Pujol RM. New-onset and exacerbations of psoriasis after mRNA COVID-19 vaccines: two sides of the same coin? J Eur Acad Dermatol Venereol. 2022;36(2):e80\u20131.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"11","key":"721_CR29","doi-asserted-by":"publisher","first-page":"e752","DOI":"10.1111\/jdv.17561","volume":"35","author":"M Lehmann","year":"2021","unstructured":"Lehmann M, Schorno P, Hunger RE, Heidemeyer K, Feldmeyer L, Yawalkar N. New onset of mainly guttate psoriasis after COVID-19 vaccination: a case report. J Eur Acad Dermatol Venereol. 2021;35(11):e752\u20135.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"372","key":"721_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"29","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;29(372): n71.","journal-title":"BMJ"},{"issue":"2","key":"721_CR31","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1001\/jamadermatol.2020.4219","volume":"157","author":"ARF Gregoire","year":"2021","unstructured":"Gregoire ARF, DeRuyter BK, Stratman EJ. Psoriasis flares following systemic glucocorticoid exposure in patients with a history of psoriasis. JAMA Dermatol. 2021;157(2):198\u2013201.","journal-title":"JAMA Dermatol"},{"issue":"2","key":"721_CR32","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1136\/bmjebm-2017-110853","volume":"23","author":"MH Murad","year":"2018","unstructured":"Murad MH, Sultan S, Haffar S, Bazerbachi F. Methodological quality and synthesis of case series and case reports. BMJ Evid Based Med. 2018;23(2):60\u20133.","journal-title":"BMJ Evid Based Med."},{"issue":"1","key":"721_CR33","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1111\/1346-8138.16203","volume":"49","author":"WJ Song","year":"2022","unstructured":"Song WJ, Lim Y, Jo SJ. De novo guttate psoriasis following coronavirus disease 2019 vaccination. J Dermatol. 2022;49(1):e30\u20131.","journal-title":"J Dermatol"},{"issue":"6","key":"721_CR34","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.clindermatol.2021.07.011","volume":"39","author":"C Magro","year":"2021","unstructured":"Magro C, Crowson AN, Franks L, Schaffer PR, Whelan P, Nuovo G. The histologic and molecular correlates of COVID-19 vaccine-induced changes in the skin. Clin Dermatol. 2021;39(6):966\u201384.","journal-title":"Clin Dermatol"},{"key":"721_CR35","doi-asserted-by":"crossref","unstructured":"Romagnuolo M, Pontini P, Muratori S, Marzano AV, Moltrasio C. De novo annular pustular psoriasis following mRNA COVID-19 vaccine. J Eur Acad Dermatol Venereol. 2022;36(8):e603\u20135.","DOI":"10.1111\/jdv.18114"},{"issue":"1","key":"721_CR36","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/ced.14895","volume":"47","author":"S Elamin","year":"2022","unstructured":"Elamin S, Hinds F, Tolland J. De novo generalized pustular psoriasis following Oxford-AstraZeneca COVID-19 vaccine. Clin Exp Dermatol. 2022;47(1):153\u20135.","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"721_CR37","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/bjd.20639","volume":"186","author":"A Catala","year":"2022","unstructured":"Catala A, Munoz-Santos C, Galvan-Casas C, Roncero Riesco M, Revilla Nebreda D, Sola-Truyols A, et al. Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases. Br J Dermatol. 2022;186(1):142\u201352.","journal-title":"Br J Dermatol"},{"key":"721_CR38","doi-asserted-by":"crossref","unstructured":"Koumaki D, Krueger-Krasagakis SE, Papadakis M, Katoulis AC, Gkiaouraki I, Zografaki K, et al. Psoriasis flare-up after AZD1222 and BNT162b2 COVID-19 mRNA vaccines: report of twelve cases from a single centre. J Eur Acad Dermatol Venereol. 2022;36(6):e411\u20135.","DOI":"10.1111\/jdv.17965"},{"key":"721_CR39","volume":"23","author":"I Durmaz","year":"2022","unstructured":"Durmaz I, Turkmen D, Altunisik N, Toplu SA. Exacerbations of generalized pustular psoriasis, palmoplantar psoriasis, and psoriasis vulgaris after mRNA COVID-19 vaccine: a report of three cases. Dermatol Ther. 2022;23: e15331.","journal-title":"Dermatol Ther"},{"issue":"10","key":"721_CR40","first-page":"e632","volume":"35","author":"PK Krajewski","year":"2021","unstructured":"Krajewski PK, Matusiak L, Szepietowski JC. Psoriasis flare-up associated with second dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine. J Eur Acad Dermatol Venereol. 2021;35(10):e632\u20134.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"721_CR41","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15110","volume":"34","author":"E Bostan","year":"2021","unstructured":"Bostan E, Elmas L, Yel B, Yalici-Armagan B. Exacerbation of plaque psoriasis after inactivated and BNT162b2 mRNA COVID-19 vaccines: a report of two cases. Dermatol Ther. 2021;34(6): e15110.","journal-title":"Dermatol Ther"},{"key":"721_CR42","doi-asserted-by":"crossref","unstructured":"Yatsuzuka K, Murakami M, Kuroo Y, Fukui M, Yoshida S, Muto J, et al. Flare-up of generalized pustular psoriasis combined with systemic capillary leak syndrome after coronavirus disease 2019 mRNA vaccination. J Dermatol. 2021;49(4):454\u20138.","DOI":"10.1111\/1346-8138.16271"},{"issue":"1","key":"721_CR43","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13075-021-02674-w","volume":"24","author":"FR Spinelli","year":"2022","unstructured":"Spinelli FR, Favalli EG, Garufi C, Cornalba M, Colafrancesco S, Conti F, et al. Low frequency of disease flare in patients with rheumatic musculoskeletal diseases who received SARS-CoV-2 mRNA vaccine. Arthritis Res Ther. 2022;24(1):21.","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"721_CR44","doi-asserted-by":"publisher","first-page":"e727","DOI":"10.1111\/jdv.17502","volume":"35","author":"L Quattrini","year":"2021","unstructured":"Quattrini L, Verardi L, Caldarola G, Peluso G, De Simone C, D\u2019Agostino M. New onset of remitting seronegative symmetrical synovitis with pitting oedema and palmoplantar psoriasis flare-up after Sars-Cov-2 vaccination. J Eur Acad Dermatol Venereol. 2021;35(11):e727\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"721_CR45","doi-asserted-by":"crossref","unstructured":"Piccolo V, Russo T, Mazzatenta C, Bassi A, Argenziano G, Cutrone M, et al. COVID vaccine-induced pustular psoriasis in patients with previous plaque type psoriasis. J Eur Acad Dermatol Venereol. 2022;36(5):e330\u20132.","DOI":"10.1111\/jdv.17918"},{"issue":"4","key":"721_CR46","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3390\/dermatopathology8040049","volume":"8","author":"D Niebel","year":"2021","unstructured":"Niebel D, Wenzel J, Wilsmann-Theis D, Ziob J, Wilhelmi J, Braegelmann C. Single-center clinico-pathological case study of 19 patients with cutaneous adverse reactions following covid-19 vaccines. Dermatopathology. 2021;8(4):463\u201376.","journal-title":"Dermatopathology"},{"issue":"1","key":"721_CR47","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15177","volume":"35","author":"ML Musumeci","year":"2022","unstructured":"Musumeci ML, Caruso G, Trecarichi AC, Micali G. Safety of SARS-CoV-2 vaccines in psoriatic patients treated with biologics: a real life experience. Dermatol Ther. 2022;35(1): e15177.","journal-title":"Dermatol Ther"},{"issue":"5","key":"721_CR48","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15055","volume":"34","author":"K Mieczkowska","year":"2021","unstructured":"Mieczkowska K, Kaubisch A, McLellan BN. Exacerbation of psoriasis following COVID-19 vaccination in a patient previously treated with PD-1 inhibitor. Dermatol Ther. 2021;34(5): e15055.","journal-title":"Dermatol Ther"},{"issue":"1","key":"721_CR49","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1016\/S2665-9913(21)00333-7","volume":"4","author":"SK Mahil","year":"2022","unstructured":"Mahil SK, Bechman K, Raharja A, Domingo-Vila C, Baudry D, Brown MA, et al. Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort study. Lancet Rheumatol. 2022;4(1):e42\u201352.","journal-title":"Lancet Rheumatol."},{"key":"721_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.812010","volume":"8","author":"YW Huang","year":"2021","unstructured":"Huang YW, Tsai TF. Exacerbation of psoriasis following COVID-19 vaccination: report from a single center. Front Med (Lausanne). 2021;8: 812010.","journal-title":"Front Med (Lausanne)."},{"issue":"2","key":"721_CR51","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/iid3.568","volume":"10","author":"M Burlando","year":"2022","unstructured":"Burlando M, Herzum A, Micalizzi C, Cozzani E, Parodi A. Cutaneous reactions to COVID-19 vaccine at the dermatology primary care. Immun Inflamm Dis. 2022;10(2):265\u201371.","journal-title":"Immun Inflamm Dis."},{"key":"721_CR52","volume":"9","author":"M Kabbani","year":"2022","unstructured":"Kabbani M, Poskin M, Benhadou F. Psoriasis exacerbation after COVID-19 vaccination in high-risk group: how to manage it? Dermatol Ther. 2022;9: e15368.","journal-title":"Dermatol Ther"},{"key":"721_CR53","volume":"15","author":"AM Nia","year":"2022","unstructured":"Nia AM, Silva MM, Spaude J, Gonzalez-Fraga JD. Erythrodermic psoriasis eruption associated with SARS-CoV-2 vaccination. Dermatol Ther. 2022;15: e15380.","journal-title":"Dermatol Ther"},{"key":"721_CR54","volume":"13","author":"R Frioui","year":"2022","unstructured":"Frioui R, Chamli A, Zaouak A, Hlel I, Khanchel F, Fenniche S, et al. A case of new-onset acute generalized pustular psoriasis following PFIZER-Biontech COVID-19 vaccine. Dermatol Ther. 2022;13: e15444.","journal-title":"Dermatol Ther"},{"issue":"2","key":"721_CR55","first-page":"199","volume":"35","author":"ED Lopez","year":"2022","unstructured":"Lopez ED, Javed N, Upadhyay S, Shekhar R, Sheikh AB. Acute exacerbation of psoriasis after COVID-19 Pfizer vaccination. Proc (Bayl Univ Med Cent). 2022;35(2):199\u2013201.","journal-title":"Proc (Bayl Univ Med Cent)."},{"key":"721_CR56","doi-asserted-by":"crossref","unstructured":"Pavia G, Gargiulo L, Spinelli F, Avagliano J, Valenti M, Borroni RG, et al. Generalized pustular psoriasis flare in a patient affected by plaque psoriasis after BNT162b2 mRNA COVID-19 vaccine, successfully treated with risankizumab. J Eur Acad Dermatol Venereol. 2022;17:1\u20133.","DOI":"10.1111\/jdv.18032"},{"key":"721_CR57","volume":"22","author":"M Rouai","year":"2022","unstructured":"Rouai M, Slimane MB, Sassi W, Alaoui F, Chelly I, Mokni M. Pustular rash triggered by Pfizer-BioNTech COVID19 vaccination: a case report. Dermatol Ther. 2022;22: e15465.","journal-title":"Dermatol Ther"},{"key":"721_CR58","volume":"20","author":"TB Tran","year":"2022","unstructured":"Tran TB, Pham NTU, Phan HN, Nguyen HT. Generalized erythrodermic psoriasis triggered by vaccination against severe acute respiratory syndrome coronavirus 2. Dermatol Ther. 2022;20: e15464.","journal-title":"Dermatol Ther"},{"issue":"11","key":"721_CR59","doi-asserted-by":"publisher","first-page":"e566","DOI":"10.1111\/1346-8138.16137","volume":"48","author":"WC Fang","year":"2021","unstructured":"Fang WC, Chiu LW, Hu SC. Psoriasis exacerbation after first dose of AstraZeneca coronavirus disease 2019 vaccine. J Dermatol. 2021;48(11):e566\u20137.","journal-title":"J Dermatol"},{"issue":"2","key":"721_CR60","doi-asserted-by":"publisher","first-page":"261","DOI":"10.34172\/hpp.2021.32","volume":"11","author":"N Onsun","year":"2021","unstructured":"Onsun N, Kaya G, I\u015f\u0131k BG, G\u00fcne\u015f B. A generalized pustular psoriasis flare after CoronaVac COVID-19 vaccination: case report. Health Promot Perspect. 2021;11(2):261\u20132.","journal-title":"Health Promot Perspect"},{"key":"721_CR61","volume":"8","author":"O Durmus","year":"2022","unstructured":"Durmus O, Akdogan N, Karadag O, Gokoz O. Erythroderma related with the first dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine in a patient with psoriasis. Dermatol Ther. 2022;8: e15363.","journal-title":"Dermatol Ther"},{"key":"721_CR62","doi-asserted-by":"publisher","first-page":"6265","DOI":"10.2147\/JIR.S341429","volume":"14","author":"Q Wang","year":"2021","unstructured":"Wang Q, Lv C, Han X, Shen M, Kuang Y. A web-based survey on factors for unvaccination and adverse reactions of SARS-CoV-2 vaccines in Chinese patients with psoriasis. J Inflamm Res. 2021;14:6265\u201373.","journal-title":"J Inflamm Res"},{"issue":"6","key":"721_CR63","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/1346-8138.15840","volume":"48","author":"F Yamazaki","year":"2021","unstructured":"Yamazaki F. Psoriasis: comorbidities. J Dermatol. 2021;48(6):732\u201340.","journal-title":"J Dermatol"},{"key":"721_CR64","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/258430","volume":"2015","author":"AT Gunes","year":"2015","unstructured":"Gunes AT, Fetil E, Akarsu S, Ozbagcivan O, Babayeva L. Possible triggering effect of influenza vaccination on psoriasis. J Immunol Res. 2015;2015: 258430.","journal-title":"J Immunol Res"},{"issue":"6","key":"721_CR65","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2340\/00015555-0496","volume":"88","author":"K Takayama","year":"2008","unstructured":"Takayama K, Satoh T, Hayashi M, Yokozeki H. Psoriatic skin lesions induced by BCG vaccination. Acta Derm Venereol. 2008;88(6):621\u20132.","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"721_CR66","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3109\/15569527.2012.727936","volume":"32","author":"VC Macias","year":"2013","unstructured":"Macias VC, Cunha D. Psoriasis triggered by tetanus-diphtheria vaccination. Cutan Ocul Toxicol. 2013;32(2):164\u20135.","journal-title":"Cutan Ocul Toxicol"},{"issue":"5","key":"721_CR67","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1136\/ard.2007.073932","volume":"67","author":"E Pattison","year":"2008","unstructured":"Pattison E, Harrison BJ, Griffiths CE, Silman AJ, Bruce IN. Environmental risk factors for the development of psoriatic arthritis: results from a case-control study. Ann Rheum Dis. 2008;67(5):672\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"721_CR68","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41591-020-01194-5","volume":"27","author":"KJ Ewer","year":"2021","unstructured":"Ewer KJ, Barrett JR, Belij-Rammerstorfer S, Sharpe H, Makinson R, Morter R, et al. T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1\/2 clinical trial. Nat Med. 2021;27(2):270\u20138.","journal-title":"Nat Med"},{"issue":"4","key":"721_CR69","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41577-021-00526-x","volume":"21","author":"JR Teijaro","year":"2021","unstructured":"Teijaro JR, Farber DL. COVID-19 vaccines: modes of immune activation and future challenges. Nat Rev Immunol. 2021;21(4):195\u20137.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"721_CR70","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/ced.14941","volume":"47","author":"B Awada","year":"2022","unstructured":"Awada B, Abdullah L, Kurban M, Abbas O. Comment on \u201cDe novo generalized pustular psoriasis following Oxford-AstraZeneca COVID-19 vaccine\u201d: possible role for Type I interferons. Clin Exp Dermatol. 2022;47(2):443.","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"721_CR71","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14498","volume":"34","author":"A Sadeghinia","year":"2021","unstructured":"Sadeghinia A, Daneshpazhooh M. Immunosuppressive drugs for patients with psoriasis during the COVID-19 pandemic era. A review. Dermatol Ther. 2021;34(1): e14498.","journal-title":"Dermatol Ther"},{"key":"721_CR72","doi-asserted-by":"crossref","unstructured":"Cristaudo A, Graceffa D, Pimpinelli F, Sperati F, Spoletini G, Bonifati C, et al. Immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in psoriasis patients treated with biologic drugs. J Eur Acad Dermatol Venereol. 2021;36(4):e266\u20138.","DOI":"10.1111\/jdv.17861"},{"issue":"7","key":"721_CR73","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1111\/ced.14723","volume":"46","author":"A Pacifico","year":"2021","unstructured":"Pacifico A, d\u2019Arino A, Pigatto PDM, Malagoli P, Young Dermatologists Italian N, Damiani G. COVID-19 vaccines do not trigger psoriasis flares in patients with psoriasis treated with apremilast. Clin Exp Dermatol. 2021;46(7):1344\u20136.","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"721_CR74","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jaad.2021.08.065","volume":"86","author":"V Pahalyants","year":"2022","unstructured":"Pahalyants V, Murphy WS, Klebanov N, Lu C, Theodosakis N, Klevens RM, et al. Immunosuppressive biologics did not increase the risk of COVID-19 or subsequent mortality: a retrospective matched cohort study from Massachusetts. J Am Acad Dermatol. 2022;86(1):252\u20135.","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"721_CR75","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1080\/14712598.2021.1965985","volume":"21","author":"M Talamonti","year":"2021","unstructured":"Talamonti M, Galluzzo M. Safety of COVID-19 vaccines in patients with psoriasis undergoing therapy with anti-interleukin agents. Expert Opin Biol Ther. 2021;21(11):1535\u20137.","journal-title":"Expert Opin Biol Ther"},{"issue":"5","key":"721_CR76","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1080\/14760584.2022.2042257","volume":"21","author":"U Kalinke","year":"2022","unstructured":"Kalinke U, Barouch DH, Rizzi R, Lagkadinou E, Tureci O, Pather S, et al. Clinical development and approval of COVID-19 vaccines. Expert Rev Vaccines. 2022;21(5):609\u201319.","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"721_CR77","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1056\/NEJMoa2116298","volume":"386","author":"EB Walter","year":"2022","unstructured":"Walter EB, Talaat KR, Sabharwal C, Gurtman A, Lockhart S, Paulsen GC, et al. Evaluation of the BNT162b2 covid-19 vaccine in children 5 to 11 years of age. N Engl J Med. 2022;386(1):35\u201346.","journal-title":"N Engl J Med"},{"issue":"21","key":"721_CR78","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1056\/NEJMoa2203315","volume":"386","author":"CB Creech","year":"2022","unstructured":"Creech CB, Anderson E, Berthaud V, Yildirim I, Atz AM, Melendez Baez I, et al. Evaluation of mRNA-1273 Covid-19 vaccine in children 6 to 11 years of age. N Engl J Med. 2022;386(21):2011\u201323.","journal-title":"N Engl J Med"},{"issue":"7821","key":"721_CR79","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/d41586-020-02386-2","volume":"584","author":"E Callaway","year":"2020","unstructured":"Callaway E. Russia\u2019s fast-track coronavirus vaccine draws outrage over safety. Nature. 2020;584(7821):334\u20135.","journal-title":"Nature"},{"issue":"4","key":"721_CR80","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13632","volume":"33","author":"R Ozaras","year":"2020","unstructured":"Ozaras R, Berk A, Ucar DH, Duman H, Kaya F, Mutlu H. Covid-19 and exacerbation of psoriasis. Dermatol Ther. 2020;33(4): e13632.","journal-title":"Dermatol Ther"},{"issue":"7","key":"721_CR81","doi-asserted-by":"publisher","first-page":"e428","DOI":"10.1111\/jdv.17256","volume":"35","author":"F Diotallevi","year":"2021","unstructured":"Diotallevi F, Campanati A, Radi G, Martina E, Rizzetto G, Barbadoro P, et al. Vaccination against SARS-CoV-2 and psoriasis: the three things every dermatologist should know. J Eur Acad Dermatol Venereol. 2021;35(7):e428\u201330.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"721_CR82","first-page":"1","volume":"30","author":"M Shahidi-Dadras","year":"2020","unstructured":"Shahidi-Dadras M, Tabary M, Robati RM, Araghi F, Dadkhahfar S. Psoriasis and risk of the COVID-19: is there a role for angiotensin converting enzyme (ACE)? J Dermatolog Treat. 2020;30:1\u20132.","journal-title":"J Dermatolog Treat"},{"key":"721_CR83","unstructured":"Valencia LS, Weng YY, Chandran NS, Ellie CC. Psoriasis flares and rebound phenomenon following exposure and withdrawal of systemic steroids\u2014a systematic review and meta-analysis. J Am Acad Dermatol. 2022;S0190-9622(22)00036-6."},{"issue":"4","key":"721_CR84","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1159\/000510712","volume":"237","author":"CW Schwarz","year":"2021","unstructured":"Schwarz CW, Loft N, Andersen V, Juul L, Zachariae C, Skov L. Are systemic corticosteroids causing psoriasis flare-ups? Questionnaire for Danish dermatologists, gastroenterologists and rheumatologists. Dermatology. 2021;237(4):588\u201394.","journal-title":"Dermatology"},{"key":"721_CR85","doi-asserted-by":"crossref","unstructured":"Muik A, Lui BG, Wallisch AK, Bacher M, Muhl J, Reinholz J, et al. Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine-elicited human sera. Science. 2022;375(6581):678\u201380.","DOI":"10.1126\/science.abn7591"},{"issue":"15","key":"721_CR86","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1056\/NEJMoa2114255","volume":"385","author":"YM Bar-On","year":"2021","unstructured":"Bar-On YM, Goldberg Y, Mandel M, Bodenheimer O, Freedman L, Kalkstein N, et al. Protection of BNT162b2 vaccine booster against Covid-19 in Israel. N Engl J Med. 2021;385(15):1393\u2013400.","journal-title":"N Engl J Med"},{"issue":"10316","key":"721_CR87","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1016\/S0140-6736(21)02249-2","volume":"398","author":"N Barda","year":"2021","unstructured":"Barda N, Dagan N, Cohen C, Hernan MA, Lipsitch M, Kohane IS, et al. Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study. Lancet. 2021;398(10316):2093\u2013100.","journal-title":"Lancet"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-022-00721-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-022-00721-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-022-00721-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,26]],"date-time":"2023-11-26T13:15:56Z","timestamp":1701004556000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-022-00721-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,1]]},"references-count":87,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["721"],"URL":"https:\/\/doi.org\/10.1007\/s40257-022-00721-z","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,1]]},"assertion":[{"value":"25 July 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was supported by research grants from the Ministry of Science and Technology, Taiwan (Grant No. MOST 108-2314-B-182A-006-MY3, 108-2320-B-182A-023-MY3, 109-2320-B-182A-008-MY3, 110-2320-B-182A-014-MY3, 108-2314-B-182A-104-MY3, 110-2326-B-182A-003-, 111-2314-B-182A-111-MY3,\u00a0111-2314-B-182A-113-MY3) and Chang Gung Memorial Hospital, Taiwan (grant no. CMRPG2J0221-2, CMRPG3L0491, CMRPG3I0381-2, CIRPG3I0024-5, CIRPG3I0044-5, CIRPG2I0014-5,\u00a0CORPG3L0471).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"None declared.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Chun-Bing Chen had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Conceptualization, P.C.W. and C.B.C.; methodology, I.H.H. and C.W.C.; software and formal analysis, P.C.W.; investigation and resources, C.C.T., W.H.C.\u00a0and C.B.C.; data curation, C.C.T., W.H.C. and C.B.C.; writing\u2014original draft preparation, P.C.W., I.H.H., C.B.C.; writing\u2014review and editing, W.H.C. and C.B.C.; visualization, P.C.W. and C.W.C.; supervision, W.H.C. and C.B.C.; funding acquisition, W.H.C. and\u00a0C.B.C. All authors have read and agreed to the published version of the manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}},{"value":"The content of this manuscript has not been published entirely or in part, is not under consideration by another journal, and will not be simultaneously submitted elsewhere.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement on any prior presentation"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}